Lv1
40 积分 2025-07-21 加入
Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial
6个月前
已完结
Practice and effects of tiered referral model for chronic non-communicable disease in Xiamen
10个月前
已关闭
厦门市"三师共管"慢性非传染性疾病分级诊疗模式的实践与效果探讨
10个月前
已关闭
Hepatocellular Carcinoma
10个月前
已完结
Cost-effectiveness of One Health interventions for rabies elimination: a systematic review
1年前
已关闭
Cost-effectiveness of One Health interventions for rabies elimination: a systematic review
1年前
已关闭
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
1年前
已完结
Is it a Chimera? A systematic review of the economic evaluations of CAR-T cell therapy
1年前
已完结
Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review
1年前
已完结
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
1年前
已完结
皖公网安备34019202002308
